Identification of VKORC1 interaction partners by split-ubiquitin system and coimmunoprecipitation

Thrombosis and Haemostasis

Volumn 105, Issue 2, 2011, Pages 285-294

  Schaafhausen, Anne ^a   Rost, Simone ^a   Oldenburg, Johannes ^b   Müller, Clemens R ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Chondrodysplasia punctata; EBP; SERP1; VKOR; Warfarin embryopathy

Indexed keywords

CELL PROTEIN; CHAPERONE; EMOPAMIL BINDING PROTEIN; ENZYME; HYDROQUINONE; REACTIVE OXYGEN METABOLITE; STRESS ASSOCIATED ENDOPLASMIC RETICULUM PROTEIN 1; UBIQUITIN; UNCLASSIFIED DRUG; VITAMIN K EPOXIDE REDUCTASE COMPLEX SUBUNIT 1; VITAMIN K GROUP;

ANTIOXIDANT ACTIVITY; ARTICLE; CHONDRODYSPLASIA PUNCTATA; CONTROLLED STUDY; EMBRYOPATHY; ENZYME SUBSTRATE; ENZYME SUBUNIT; GENE MUTATION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; INTERNATIONAL NORMALIZED RATIO; NUCLEOTIDE SEQUENCE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN TARGETING; TWO HYBRID SYSTEM; UNINDEXED SEQUENCE; X CHROMOSOME LINKED DISORDER;

CHONDRODYSPLASIA PUNCTATA; HEK293 CELLS; HELA CELLS; HUMANS; IMMUNOPRECIPITATION; MICROSCOPY, FLUORESCENCE; MIXED FUNCTION OXYGENASES; MUTATION; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTEIN MULTIMERIZATION; STEROID ISOMERASES; TRANSFECTION; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 79851474619     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH10-07-0483     Document Type: Article

References (50)

1. Benzakour O. Vitamin K-dependent proteins: Functions in blood coagulation and beyond. Thromb Haemost 2008; 100: 527-529.
2. Fregin A, Rost S, Wolz W, et al. Homozygosity mapping of a second gene locus for hereditary combined deficiency of vitamin K - dependent clotting factors to the centromeric region of chromosome 16. Blood 2002; 100: 3229-3232. (Pubitemid 35217071)
3. Oldenburg J, von Brederlow B, Fregin A, et al. Congenital deficiency of vitamin K dependent coagulation factors in two families presents as a genetic defect of the vitamin K-epoxide-reductase-complex. Thromb Haemost 2000; 84: 937-941. (Pubitemid 32014026)
4. Shearer MJ, Newman P. Metabolism and cell biology of vitamin K. Thromb Haemost 2008; 100: 530-547.
5. Hauschka P, Lian J, Cole D, et al. Osteocalcin and Matrix Gla Protein: Vitamin K-Dependent Proteins in Bone. Physiol Rev 1989; 69: 990-1047. (Pubitemid 19184853)
6. Weitz J. New oral anticoagulants in development. Thromb Haemost 2010; 103: 62-70.
7. Rost S, Fregin A, Ivaskevicius V, et al. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature 2004; 427: 537-541. (Pubitemid 38209110)
8. Wilms EB, Touw DJ, Conemans JMH, et al. A new VKORC1 allelic variant (p.Trp59Arg) in a patient with partial resistance to acenocoumarol and phenprocoumon. J Thromb Haemost 2008; 6: 1224-1226. (Pubitemid 351859132)
9. Pelz H-J, Rost S, Hünerberg M, et al. The genetic basis of resistance to anticoagulants in rodents. Genetics 2005; 170: 1839-1847. (Pubitemid 41362835)
10. Menger H, Lin AE, Toriello HV, et al. Vitamin K Deficiency Embryopathy: A Phenocopy of the Warfarin Embryopathy Due to a Disorder of Embryonic Vitamin K Metabolism. Am J Med Genet 1997; 72: 129-134. (Pubitemid 27426076)
11. Watzka M, Geisen C, Bevans CG, et al. Thirteen novel VKORC1 mutations associated with oral anticoagulant resistance: insight into improved patient diagnosis and treatment. J Thromb Haemost 2010; Epub ahead of print.
12. Spohn G, Kleinridders A, Wunderlich F, et al. VKORC1 deficiency in mice causes early postnatal lethality due to severe bleeding. Thromb Haemost 2009; 101: 1044-1050.
13. Watzka M, Westhofen P, Hass M, et al. Polymorphisms in VKORC1 and GGCX are not major genetic determinants of vitamin K-dependent coagulation factor activity in Western Germans. Thromb Haemost 2009; 102: 418-420.
14. Klein T, Altman R, Eriksson N, et al., with International Warfarin Pharmacogenetics Consortium. Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data. N Engl J Med 2009; 360: 753-764.
15. Geisen C, Watzka M, Sittinger K, et al. VKORC1 haplotypes and their impact on the inter-individual and inter-ethnical variability of oral anticoagulation. Thromb Haemost 2005; 94: 773-779. (Pubitemid 41489236)
16. Oldenburg J, Bevans CG, Fregin A, et al. Current pharmacogenetic developments in oral anticoagulation therapy: the influence of variant VKORC1 and CYP2C9 alleles. Thromb Haemost 2007; 98: 570-576.
17. Goodstadt L, Ponting CP. Vitamin K epoxide reductase: homology, active site and catalytic mechanism. Trends Biochem Sci 2004; 29: 289-292. (Pubitemid 38968759)
18. Li W, Schulman S, Dutton RJ, et al. Structure of a bacterial homologue of vitamin K epoxide reductase. Nature 2010; 463: 507-512.
19. Schulman S, Wang B, Li W, et al. Vitamin K epoxide reductase prefers ER membrane-anchored thioredoxin-like redox partners. Proc Natl Acad Sci USA 2010; 107: 15027-15032.
20. Cain D, Hutson SM, Wallin R. Assembly of the Warfarin-sensitive Vitamin K 2,3-Epoxide Reductase Enzyme Complex in the Endoplasmic Reticulum Membrane. J Biol Chem 1997; 272: 29068-29075. (Pubitemid 27498194)
21. Cain D, Hutson SM, Wallin R. Warfarin Resistance Is Associated with a Protein Component of the Vitamin K 2,3-Epoxide Reductase Enzyme Complex in Rat Liver. Thromb Haemost 1998; 80: 128-133. (Pubitemid 28353511)
22. Wallin R, Hutson SM, Cain D, et al. A molecular mechanism for genetic warfarin resistance in the rat. FASEB J 2001; 15: 2542-2544.
23. Wajih N, Sane DC, Hutson SM, et al. The Inhibitory Effect of Calumenin on the Vitamin K-dependent gamma-Carboxylation System. J Biol Chem 2004; 279: 25276-25283.
24. Chu P-H, Huang T-Y, Williams J, et al. Purified vitamin K epoxide reductase alone is sufficient for conversion of vitamin K epoxide to vitamin K and vitamin K to vitamin KH 2. Proc Natl Acad Sci USA 2006; 103: 19308-19313. (Pubitemid 46026028)
25. Wajih N, Hutson SM, Wallin R. Disulfide-dependent Protein Folding Is Linked to Operation of the Vitamin K Cycle in the Endoplasmic Reticulum. J Biol Chem 2007; 282: 2626-2635.
26. Rost S, Pelz H-J, Menzel S, et al. Novel mutations in the VKORC1 gene of wild rats and mice - a response to 50 years of selection pressure by warfarin? BMC Genet 2009; 610: 4.
27. Stagljar I, Korostensky C, Johnsson N, et al. A genetic system based on split-ubiquitin for the analysis of interactions between membrane proteins. Proc Natl Acad Sci USA 1998; 95: 5187-5192. (Pubitemid 28208573)
28. Kittanakom S, Chuk M, Wong V, et al. Analysis of Membrane Protein Complexes Using the Split-Ubiquitin Membrane Yeast Two-Hybrid (MYTH) System. Methods Mol Biol 2009; 548: 247-271.
29. Wadelius M, Chen LY, Eriksson N, et al. Association of warfarin dose with genes involved in its action and metabolism. Hum Genet 2007; 121: 23-34. (Pubitemid 46421137)
30. Moebius FF, Fitzky BU, Wietzorrek G, et al. Cloning of an emopamil-binding protein (EBP)-like protein that lacks sterol delta 8 - delta 7 isomerase activity. Biochem J 2003; 237: 229-237. (Pubitemid 37046947)
31. Okiyama K, Smith DH, Thomas MJ, et al. Evaluation of a novel calcium channel blocker, (S)-emopamil, on regional cerebral edema and neurobehavioral function after experimental brain injury. J Neurosurg 1992; 77: 607-615.
32. Yamaguchi A, Hori O, Stern DM, et al. Stress-associated Endoplasmic Reticulum Protein 1 (SERP1)/Ribosome-associated Membrane Protein 4 (RAMP4) Stabilizes Membrane Proteins during Stress and Facilitates Subsequent Glycosylation. Cell 1999; 147: 1195-1204. (Pubitemid 30012806)
33. Silve S, Dupuy PH, Labit-Lebouteiller C, et al. Emopamil-binding Protein, a Mammalian Protein That Binds a Series of Structurally Diverse Neuroprotective Agents, Exhibits delta8-delta7 Sterol Isomerase Activity in Yeast. J Biol Chem 1996; 271: 22434-22440. (Pubitemid 26304678)
34. Hori O, Miyazaki M, Tamatani T, Ozawa K, Takano K, Okabe M, et al. Deletion of SERP1/RAMP4, a Component of the Endoplasmic Reticulum (ER) Translocation Sites, Leads to ER Stress. Mol Cell Biol. 2006; 26: 4257-4267. (Pubitemid 43788024)
35. Chien C-T, Bartel PL, Sternglanz R, et al. The two-hybrid system: A method to identify and clone genes for proteins that interact with a protein of interest. Proc Natl Acad Sci USA 1991; 88: 9578-9582. (Pubitemid 21915674)
36. Gross E, Kastner DB, Kaiser CA, et al. Structure of Ero1p, Source of Disulfide Bonds for Oxidative Protein Folding in the Cell. Cell 2004; 117: 601-610.
37. Tu BP, Weissman JS, Francisco S. The FAD- and O 2 -Dependent Reaction Cycle of Ero1-Mediated Oxidative Protein Folding in the Endoplasmic Reticulum. Mol Cell 2002; 10: 983-994. (Pubitemid 35453820)
38. Chakravarthi S, Jessop CE, Bulleid NJ. The role of glutathione in disulphide bond formation and endoplasmic-reticulum-generated oxidative stress. EMBO Rep 2006; 7: 1-5.
39. Mukai K, Morimoto H, Kikuchi S, et al. Kinetic study of free-radical-scavenging action of biological hydroquinones (reduced forms of ubiquinone, vitamin K and tocopherol quinone) in solution. Biochim Biophys Acta 1993; 1157: 313-317. (Pubitemid 23207814)
40. Mukai K, Itoh S, Morimoto H. Stopped-flow Kinetic Study of Vitamin E Regeneration Reaction with Biological Hydroquinones (Reduced Forms of Ubiquinone, Vitamin K, and Tocopherolquinone) in Solution. J Biol Chem 1992; 267: 22277-22281.
41. Vervoort LM, Ronden JE, Thijssen HH. The Potent Antioxidant Activity of the Vitamin K Cycle in Microsomal Lipid Peroxidation. Biochem Pharmacol 1997; 54: 871-876. (Pubitemid 27404594)
42. Li J, Lin JC, Wang H, et al. Novel Role of Vitamin K in Preventing Oxidative Injury to Developing Oligodendrocytes and Neurons. J Neurosci 2003; 23: 5816-5826. (Pubitemid 36807861)
43. Braverman N, Lin P, Moebius FF, et al. Mutations in the gene encoding 3 beta-hydroxysteroid-delta 8, delta 7-isomerase cause X-linked dominant Conradi-Hünermann syndrome. Nat Genet 1999; 22: 291-294. (Pubitemid 29297258)
44. Hello M, David A, Barbarot S. Conradi-Hünermann-Happle syndrome with unilateral distribution. Ann Dermatol Venereol 2010; 137: 44-47.
45. Hall JG, Pauli RM, Wilson KM. Maternal and Fetal Sequelae of Anticoagulation During Pregnancy. Am J Med 1980; 68: 122-140. (Pubitemid 10207628)
46. Pauli RM, Lian JB, Mosher DF, et al. Association of Congenital Deficiency of Multiple Vitamin K-dependent Coagulation Factors and the Phenotype of the Warfarin Embryopathy: Clues to the Mechanism of Teratogenicity of Coumarin Derivatives. Am J Hum Genet 1987; 41: 566-583. (Pubitemid 18031530)
47. Cozzolino M. Matrix-Gla protein and vascular calcification: the negative role of oral anticoagulant therapy. Thromb Haemost 2009; 101: 605-606.
48. Cranenburg ECM, Schurgers LJ, Vermeer C. Vitamin K: The coagulation vitamin that became omnipotent. Thromb Haemost 2007; 98: 120-125. (Pubitemid 47074186)
49. Smadja DM, Loriot M, Hindorff LA, et al. No clear link between VKORC1 genetic polymorphism and the risk of venous thrombosis or peripheral arterial disease. Thromb Haemost 2008; 99: 970-972. (Pubitemid 351705321)
50. Soute BAM, Spronk HMH, Mutucumarana VP, et al. Characteristics of recombinant W501S mutated human gamma-glutamyl carboxylase. J Thromb Haemost 2004; 2: 597-604. (Pubitemid 40185683)